Results 111 to 120 of about 333 (138)

Pharmacological Analysis of the Therapeutic Effect of Radioprotectors Cystamine and Indralin in the Capacity of Radiomitigators

open access: yesBulletin of Experimental Biology and Medicine, 2017
The therapeutic radiomitigating effect of cystamine and indralin was studied in experiments on mice and rats and pharmacological analysis of these drugs was carried out. The animals were subjected to whole-body 60Co γ-irradiation. The mice were exposed to single (9-10 Gy) or double (8 Gy) irradiation with an interval of 1 month.
A A Galkin, I B Ushakov, M V Vasin
exaly   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

Study of the Potential Radiomitigator Effect of Quercetin on Human Lymphocytes

Inflammation, 2018
Several substances of synthetic and natural origin have been studied to determine their ability to protect the body from damage caused by ionizing radiation. Among these substances, quercetin has been shown to be a naturally occurring molecule with high radioprotective and radiomitigator potential due to its antioxidant properties.
Williams Nascimento de Siqueira   +11 more
openaire   +2 more sources

Preclinical pharmacokinetics of the radiomitigator KZ-41 in rats

Xenobiotica, 2011
KZ-41, a quinic acid derivative, significantly reduces mortality in a murine model of hematopoietic acute radiation syndrome. The purpose of this study was to evaluate the systemic pharmacokinetics, elimination, and oral bioavailability of KZ-41 in rats.
Kui, Zeng   +4 more
openaire   +2 more sources

Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation. [PDF]

open access: yesRadiation Research, 2015
Although radiation therapy is an important cancer treatment modality, patients may experience adverse effects. The use of a radiation-effect modulator may help improve the outcome and health-related quality of life (HRQOL) of patients undergoing radiation therapy either by enhancing tumor cell killing or by protecting normal tissues.
Pataje G S Prasanna   +2 more
exaly   +3 more sources

Analysis of a Metalloporphyrin Antioxidant Mimetic (MnTE-2-PyP) as a Radiomitigator: Prostate Tumor and Immune Status

open access: yesTechnology in Cancer Research and Treatment, 2012
Due to radiation-induced immune depression and development of pathologies such as cancer, there is increasing urgency to identify radiomitigators that are effective when administered after radiation exposure. The main goal of this study was to determine the radiomitigation capacity of MnTE-2-PyP[Mn(III) tetrakis (N-ethylpyridinium-2-yl) porphyrin], a ...
Michael J Pecaut, J M Slater
exaly   +3 more sources

STUDY OF RADIOMITIGATOR PROPERTIES OF MYOTIVE

XI Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов, молекулярных биологов и специалистов фундаментальной медицины — 2024 : сб. тез.
It is known that NMR spectroscopy can be effectively used to detect metabolic changes in the blood and urine caused by partial and total body irradiation [1]. The purpose of our work was to study changes in the composition of metabolites of erythrocytes by NMR spectroscopy after administration of the drug MYOTIVE to rats irradiated with γ-radiation at ...
A.S. Bykov   +7 more
openaire   +1 more source

Radiomitigation and Tissue Repair Activity of Systemically Administered Therapeutic Peptide TP508 Is Enhanced by PEGylation

The AAPS Journal, 2017
TP508 is a synthetically derived tissue repair peptide that has previously demonstrated safety and potential efficacy in phase I/II clinical trials for the treatment of diabetic foot ulcers. Recent studies show that a single injection of TP508 administered 24 h after irradiation significantly increases survival and delays mortality in murine models of ...
Scott D, McVicar   +2 more
openaire   +2 more sources

Quinic Acid Derivative KZ‐41 Exhibits Radiomitigating Activity in Preclinical Models of Radiation Injury

Drug Development Research, 2013
Abstract Preclinical Research Acute radiation syndrome is induced when a significant portion of the body receives high‐dose, as well as high‐dose rate, radiation. We have previously identified a quinic acid‐based derivative, KZ‐41, that protects from radiation injury.
Karin E, Thompson   +5 more
openaire   +2 more sources

[Radiomitigators: prospects for use in medical radiation protection].

Voenno-meditsinskii zhurnal, 2014
Prospects of creation and use of radiomitigators--the treatment-and-prophylactic means intended for rendering medical care by the victim of influence of ionizing radiation in the earliest terms after irradiation (hours, days) are presented. It is shown that the most effective radiomitigators are found among natural biopolymers of a microbic origin (a ...
A N, Grebeniuk   +2 more
openaire   +1 more source

Pharmacokinetics, pharmacodynamics, and radiomitigative efficacy of IEPA in a non-human primate model of acute radiation syndrome

International Journal of Radiation Biology
The acute radiation syndrome (ARS) represents a significant public health threat following nuclear exposure, with limited available medical countermeasures (MCMs). Imidazolyl ethanamide pentandioic acid (IEPA), a novel orally bioavailable small molecule, has demonstrated radioprotective effects in rodent models earlier.
Radoslaw Wesolowski   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy